Chief Financial Officer · TriSalus Life Sciences, Inc. · TriSalus Life Sciences, Inc. — Employee Stock Option (right to buy)
Side
A
Value
—
Shares
130.0K
Price
—
Executed
Nov 24, 2025
Disclosed
Nov 25, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 24 executedNov 25, 2025 disclosed
TLSI · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 24.1% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
TriSalus Life Sciences, Inc. — Employee Stock Option (right to buy)
Ticker
TLSI
Shares
130.0K
Price per share
$0
Execution date (reported)
Nov 24, 2025
Owned after transaction
668.9K shares
Days from execution to publication
1
What this establishes
Patience David filed this Form 4 reporting a grant or award of TLSI on Nov 24, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Patience Davidcik:0001970009
Issuer
TriSalus Life Sciences, Inc.cik:0001826667
Revision history · 0
No field has changed since this record was first ingested.
